InterK Peptide Therapeutics
Business Services · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
25 Sirius Rd Enter Via Mars Rd, Lane Cov...Phone Number
+61 418212254Website
www.interk.com.auRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About InterK Peptide Therapeutics
InterK Peptide Therapeutics is a preclinical biotechnology company based in Sydney, Australia, specializing in the development of small, non-naturally occurring peptides that modulate the immune system. Their innovative compounds aim to provide benefits in treating autoimmune diseases, enhancing cancer immunotherapy, supporting anti-viral vaccination strategies, and repairing skin damage from ultraviolet radiation. The company focuses on preclinical development of peptide-based therapeutic candidates. Their intended clients include healthcare providers and researchers in the fields of immunology and oncology.Explore more
InterK Peptide Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is InterK Peptide Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if InterK Peptide Therapeutics is spiking on competitors!
Click to see if InterK Peptide Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when InterK Peptide Therapeutics launches new products
Funding: Get notified immidiatlly once InterK Peptide Therapeutics has new funding data
Earning: See what the market has to say on InterK Peptide Therapeutics recently announced quarterly report
Check if InterK Peptide Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at InterK Peptide Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
InterK Peptide Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to InterK Peptide Therapeutics
Compare insights from companies similar to InterK Peptide Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
InterK Peptide Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
InterK Peptide Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about InterK Peptide Therapeutics.
InterK Peptide Therapeutics Tech Stack
A closer look at the technologies used by InterK Peptide Therapeutics
See more technologies
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding InterK Peptide Therapeutics
Sign Up For FreeTo access detailed company insights
InterK Peptide Therapeutics is a preclinical biotechnology company based in Sydney, Australia, specializing in the development of small, non-naturally occurring peptides that modulate the immune system. Their innovative compounds aim to provide benefits in treating autoimmune diseases, enhancing cancer immunotherapy, supporting anti-viral vaccinati... Read More
